{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:37:11Z","timestamp":1787841431121,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) infection, predominantly transmitted by exposure to infected blood, remains one of the major public health problems worldwide. This study aims to identify the risk factors of HCV transmission and its chronic complications among the study group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This retrospective study was approved by the Research and Ethical Review and Approve Committee (RERAC) of Oman and conducted at a secondary-care hospital situated in the North Batinah region of Oman. The study population included all HCV cases confirmed by positive serology and reverse-transcription polymerase chain reaction tests during their presence at the hospital between January 2017 and December 2022. The relevant data of the study population were retrieved from the hospital electronic health record system. The data were analyzed using the Statistical Package for the Social Sciences (SPSS), Version 26.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>A total of 177 HCV confirmed cases were included in the study. HCV infection was predominant among males (74%) and individuals of the age group of 21\u201360 years (74.6%). Genotyping was possible only in 107 cases. Among HCV genotypes, genotype 3 (58.9%) was the most frequently identified, followed by genotype 1 (34.6%). Hemodialysis (21.5%), history of blood transfusion (16.4%), and injection drug use (11.9%) were the major risk factors for HCV infection, while cirrhosis (7.3%) and fatty liver disease (4%) were the most frequently observed chronic HCV complications. HCV infection in the spouse\/partner (21.5%), alcohol use (7.3%), and co-infection with hepatitis B virus (2.3%) and human immunodeficiency virus (1.7%) were the other significant factors detected in our study population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>HCV is a multi-factorial disease leading to severe chronic complications, thus representing a public health threat. This clearly emphasizes the cruciality of HCV community awareness campaigns and enhancement of Omani national guidelines for early screening of high-risk groups as well as effective management of HCV-infected cases to reduce the substantial burden of the disease on patients as well as the healthcare system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_1326_23","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T12:00:08Z","timestamp":1720785608000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study"],"prefix":"10.4103","volume":"13","author":[{"given":"Mohan B.","family":"Sannathimmappa","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Zehri","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat A. M.","family":"Al Zadjali","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima M. A.","family":"Albalushi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buthaina A. A. H.","family":"Al Saadi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Aravindakshan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham S.","family":"Al-Risi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Blood Bank, Sohar Hospital, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleema","family":"Al-Maqbali","sequence":"additional","affiliation":[{"name":"Department of Pathology and Blood Bank, Sohar Hospital, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Nambiar","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine and Health Sciences, National University of Science and Technology, Sohar Campus, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-020-00669-4","article-title":"Hepatitis C virus vaccine design: Focus on the humoral immune response","volume":"27","author":"Sepulveda-Crespo","year":"2020","journal-title":"J Biomed Sci"},{"key":"R2-20240828","first-page":"44","article-title":"Hepatitis C virus (HCV) infection in Africa: A review","volume":"14","author":"Karoney","year":"2013","journal-title":"Pan Afr Med J"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiph.2019.11.015","article-title":"Overview of hepatitis C infection, molecular biology, and new treatment","volume":"13","author":"Rabaan","year":"2020","journal-title":"J Infect Public Health"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/pathogens12030432","article-title":"Challenges facing viral hepatitis C elimination in Lebanon","volume":"12","author":"Ayoub","year":"2023","journal-title":"Pathogens"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virusres.2007.02.001","article-title":"Quasispecies and its impact on viral hepatitis","volume":"127","author":"Domingo","year":"2007","journal-title":"Virus Res"},{"key":"R6-20240828","article-title":"Hepatitis C","year":"2017"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/1319-3767.41727","article-title":"Hepatitis C and poor quality of life: Is it the virus or the patient?","volume":"14","author":"Abdo","year":"2008","journal-title":"Saudi J Gastroenterol"},{"key":"R8-20240828","article-title":"Hepatitis C questions and answers for health professionals","year":"2020"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jare.2016.06.001","article-title":"Hepatitis C virus and cardiovascular: A review","volume":"8","author":"Petta","year":"2017","journal-title":"J Adv Res"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jvh.12979","article-title":"Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients","volume":"26","author":"Dirks","year":"2019","journal-title":"J Viral Hepat"},{"key":"R12-20240828","first-page":"58","article-title":"Viral hepatitis as a risk factor for the development of hepatocellular carcinoma","volume":"6","author":"Alqahtani","year":"2020","journal-title":"Hepatoma Res"},{"key":"R13-20240828","article-title":"Global health sector strategies 2022-2030"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41598-023-29262-z","article-title":"Gender differences in prevalence of hepatitis C virus infection in Egypt: A systematic review and meta-analysis","volume":"13","author":"Abdel-Gawad","year":"2023","journal-title":"Sci Rep"},{"key":"R15-20240828","article-title":"The authoritative resource for epidemiological data, modeling tools, training, and decision analytics to support global elimination of hepatitis B and C by 2030"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.18295\/squmj.2017.17.04.005","article-title":"Epidemiology of chronic hepatitis C infections at a tertiary care centre in Oman","volume":"17","author":"Al-Busafi","year":"2017","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R17-20240828","first-page":"e17480","article-title":"Gender-specific frequency distribution of hepatitis C virus genotypes in Punjab province, Pakistan: A clinically significant descriptive cross-sectional study","volume":"13","author":"Yousaf","year":"2021","journal-title":"Cureus"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1186\/s12889-019-7640-1","article-title":"Mass screening for hepatitis B and C in southern upper Egypt","volume":"19","author":"Soliman","year":"2019","journal-title":"BMC Public Health"},{"key":"R19-20240828","first-page":"987","article-title":"Distribution of hepatitis C virus genotypes in Dubai, United Arab Emirates","volume":"60","author":"Abro","year":"2010","journal-title":"J Pak Med Assoc"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00705-004-0363-2","article-title":"Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients","volume":"149","author":"Bozdayi","year":"2004","journal-title":"Arch Virol"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"e40357","DOI":"10.5812\/hepatmon.40357","article-title":"The distribution of hepatitis C virus genotypes in Middle Eastern countries: A systematic review and meta-analysis","volume":"16","author":"Ghaderi-Zefrehi","year":"2016","journal-title":"Hepat Mon"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9071(199905)58:1<44::AID-JMV6>3.0.CO;2-U","article-title":"Hepatitis C genotypes and subtypes in Saudi Arabia","volume":"58","author":"Shobokshi","year":"1999","journal-title":"J Med Virol"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/BF01718613","article-title":"Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: Application to isolates from Egyptian and Yemeni patients","volume":"141","author":"Ohno","year":"1996","journal-title":"Arch Virol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.51.3.429","article-title":"Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: A multicentre study in 2796 patients","volume":"51","author":"Hinrichsen","year":"2002","journal-title":"Gut"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.3748\/wjg.v23.i20.3569","article-title":"Hepatitis C in injection drug users: It is time to treat","volume":"23","author":"Grassi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: A modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1055\/s-0040-1709185","article-title":"Hepatitis C virus infection in children and pregnant women: An updated review of the literature on screening and treatments","volume":"10","author":"Ragusa","year":"2020","journal-title":"AJP Rep"},{"key":"R28-20240828","first-page":"232","article-title":"Hepatitis C and alcohol","volume":"27","author":"Schiff","year":"2003","journal-title":"Alcohol Res Health"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"ofaa095","DOI":"10.1093\/ofid\/ofaa095","article-title":"Re-treatment of hepatitis C infection after multiple failures of direct-acting antiviral therapy","volume":"7","author":"Fierer","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"g3308","DOI":"10.1136\/bmj.g3308","article-title":"Antiviral treatment of hepatitis C","volume":"348","author":"Feeney","year":"2014","journal-title":"BMJ"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1326_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:54:55Z","timestamp":1787838895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1326_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_1326_23","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"2023-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}